Advanced company searchLink opens in new window

CNX THERAPEUTICS LIMITED

Company number 03363032

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
01 Sep 2021 TM01 Termination of appointment of Thomas Edward Gibbs as a director on 17 August 2021
01 Sep 2021 TM02 Termination of appointment of Gregory M Bokar as a secretary on 17 August 2021
01 Sep 2021 TM01 Termination of appointment of Stephen Leslie Freeman as a director on 17 August 2021
01 Sep 2021 TM01 Termination of appointment of Gregory M Bokar as a director on 17 August 2021
01 Sep 2021 PSC02 Notification of Solar Bidco Limited as a person with significant control on 17 August 2021
01 Sep 2021 PSC07 Cessation of Sumitomo Dainippon Pharma Co., Ltd. as a person with significant control on 17 August 2021
01 Sep 2021 AD04 Register(s) moved to registered office address First Floor Southside 97-105 Victoria Street London SW1E 6QT
01 Sep 2021 AP01 Appointment of Mr Terry John Petersen as a director on 17 August 2021
01 Sep 2021 AP01 Appointment of Ms Olga Feodorovna Lund as a director on 17 August 2021
23 Aug 2021 RESOLUTIONS Resolutions
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2021-08-20
12 May 2021 CS01 Confirmation statement made on 1 May 2021 with no updates
01 Dec 2020 AA Full accounts made up to 31 March 2020
01 May 2020 CS01 Confirmation statement made on 1 May 2020 with no updates
02 Apr 2020 AP01 Appointment of Stephen Leslie Freeman as a director on 1 April 2020
02 Apr 2020 TM01 Termination of appointment of Shinichiro Katayanagi as a director on 31 March 2020
06 Dec 2019 AP01 Appointment of Thomas Edward Gibbs as a director on 5 December 2019
19 Jul 2019 AP01 Appointment of Gregory M Bokar as a director on 15 July 2019
19 Jul 2019 AP01 Appointment of Shinichiro Katayanagi as a director on 15 July 2019
11 Jun 2019 AA Full accounts made up to 31 March 2019
06 Jun 2019 TM01 Termination of appointment of David Frawley as a director on 31 May 2019
07 May 2019 CS01 Confirmation statement made on 1 May 2019 with no updates
12 Apr 2019 AP01 Appointment of Dr. Antony Loebel as a director on 1 April 2019
12 Apr 2019 TM01 Termination of appointment of Nobuhiko Tamura as a director on 31 March 2019
14 May 2018 AA Full accounts made up to 31 March 2018
04 May 2018 CS01 Confirmation statement made on 1 May 2018 with no updates